Driving Better Diabetes Research with Cyntegrity’s Diabetes-Focused RACT
Diabetes research continues to grow rapidly, and with that growth comes the need for smarter planning, cleaner data, and stronger oversight. Many study teams still struggle with identifying the right risks early enough or keeping a consistent focus on what matters most for patient safety and data integrity.
Cyntegrity’s Diabetes-focused RACT (Risk Assessment and Categorization Tool) was designed exactly for this challenge. It gives research teams a structured way to understand the real risks in diabetes trials and to manage them before they turn into problems.
Why a Diabetes-Specific RACT Matters
Diabetes trials have their own patterns:
- frequent patient-reported outcomes
- intensive monitoring needs
- adherence-related challenges
- variability in glucose measurements
- multiple digital devices and wearables
- high data-collection frequency
A general risk tool often misses these details. Cyntegrity’s RACT focuses directly on them, helping teams see the typical pressure points of a diabetes study.
What Cyntegrity’s Diabetes RACT Brings to Study Teams
- Ready-to-use structure
The tool includes predefined risk categories relevant to diabetes studies, so teams don’t have to start from zero. - Smarter prioritization
Instead of treating all risks equally, the RACT highlights the ones that can genuinely impact safety or data reliability. - Aligned with ICH E6(R3)
It supports a modern RBQM approach by encouraging early risk identification, cross-functional review, and continuous oversight. - Supports consistent decision-making
Study teams across sites and countries can speak the same “risk language,” reducing variability and misunderstandings. - Integrates with MyRBQM® Portal
For teams using Cyntegrity’s ecosystem, the RACT connects naturally to KRIs, quality tolerance limits, and ongoing monitoring dashboards.
How It Helps Sponsors and CROs
- fewer protocol deviations linked to glucose monitoring
- fewer data quality issues
- clearer audit and inspection readiness
- stronger documentation of risk-based decisions
- reduced site burden through more targeted monitoring
The tool translates complex diabetes study dynamics into actionable insights.
A Useful Tool for a High-Impact Therapeutic Area
Diabetes is one of the world’s fastest-growing public health challenges. Improving how diabetes trials are designed and monitored is an important step toward improving future treatments and toward supporting the millions of people living with diabetes.
Cyntegrity’s Diabetes RACT helps teams run these studies with more confidence, clarity, and control.
Final Thoughts
With the right risk-based tools in place, diabetes research becomes not only safer and more efficient, but also more meaningful for the patients who rely on these studies. When teams can focus on the real risks, respond quickly to early signals, and maintain clean, reliable data, every decision made during the trial gains value.
Cyntegrity’s Diabetes RACT supports this mindset, helping research teams stay aligned, informed, and confident as they work toward better outcomes for everyone affected by diabetes.
